Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
2026 report on Direct Meds' compounded semaglutide and tirzepatide GLP-1 program, including pricing, telehealth process, and delivery formats.
-
Esaote unveils MyLab E85 GTS ultrasound in Vienna, combining fusion imaging and ablation confirmation to boost precision in interventional radiology today.
-
MANNKIND TO PRESENT NEW DATA FROM PEDIATRIC AND ADULT STUDIES OF AFREZZA® AT ATTD 2026
-
VelocityEHS will showcase it AI-powered Industrial Ergonomics innovations, including a preview of its AI Hands & Wrists Assessment at AEC.
-
TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
-
TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
-
neffy delivers $72.2 million of U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million...
-
FluffCo Luxury Hotel Pillow marketing claims, materials, pricing, and hotel-quality positioning evaluated in latest 2026 consumer report.
-
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial...
-
VIENNA, Austria, March 05, 2026 (GLOBE NEWSWIRE) -- Easy to transport, featuring compact size and high-quality images, developed to revolutionise and facilitate the work of interventional radiologists...